The American Chemical Society (ACS) expresses strong disappointment with the Environmental Protection Agency’s (EPA’s) recent decision to finalise a rule changing the nature of the data and scientific information used in rulemaking, ‘Strengthening Transparency in Pivotal Science Underlying Significant Regulatory Actions and Influential Scientific Information.’ ACS urges the incoming Biden administration, as well as the 117th Congress, to move swiftly to review and make necessary changes to the regulation.
The rule would allow EPA to eliminate scientific information when considering major regulatory actions, while also giving the agency’s administrator excessive authority to pick and choose which data career staff use when considering rulemaking. Studies using confidential personal health information could be excluded, leaving policymakers in the dark about potential health and safety effects.
Click here to read the original press release.
